Condensed Consolidated Statements of Stockholders’ Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit
Balance at the beginning of the period (in shares) at Dec. 31, 2022		44,828
Balance at the beginning of the period at Dec. 31, 2022	$ 197,072	$ 0	$ 545,753	$ (6)	$ (348,675)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans (in shares)		181
Issuance of common stock under stock plans	380		380
Stock-based compensation expense	4,137		4,137
Unrealized gain (loss) on cash equivalents	21			21
Net loss	(28,484)				(28,484)
Balance at the end of the period (in shares) at Mar. 31, 2023		45,009
Balance at the end of the period at Mar. 31, 2023	173,126	$ 0	550,270	15	(377,159)
Balance at the beginning of the period (in shares) at Dec. 31, 2022		44,828
Balance at the beginning of the period at Dec. 31, 2022	197,072	$ 0	545,753	(6)	(348,675)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized gain (loss) on cash equivalents	0
Net loss	(78,393)
Balance at the end of the period (in shares) at Sep. 30, 2023		50,473
Balance at the end of the period at Sep. 30, 2023	299,356	$ 0	726,428	(6)	(427,066)
Balance at the beginning of the period (in shares) at Mar. 31, 2023		45,009
Balance at the beginning of the period at Mar. 31, 2023	173,126	$ 0	550,270	15	(377,159)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans (in shares)		262
Issuance of common stock under stock plans	2,430		2,430
Stock-based compensation expense	5,652		5,652
Unrealized gain (loss) on cash equivalents	(21)			(21)
Net loss	(25,285)				(25,285)
Balance at the end of the period (in shares) at Jun. 30, 2023		45,271
Balance at the end of the period at Jun. 30, 2023	155,902	$ 0	558,352	(6)	(402,444)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans (in shares)		117
Issuance of common stock under stock plans	414		414
Issuance of common stock, net of issuance costs (in shares)		5,085
Issuance of common stock, net of issuance costs of 10,795	161,705		161,705
Stock-based compensation expense	5,957		5,957
Unrealized gain (loss) on cash equivalents	0			0
Net loss	(24,622)				(24,622)
Balance at the end of the period (in shares) at Sep. 30, 2023		50,473
Balance at the end of the period at Sep. 30, 2023	$ 299,356	$ 0	726,428	(6)	(427,066)
Balance at the beginning of the period (in shares) at Dec. 31, 2023	50,771	50,771
Balance at the beginning of the period at Dec. 31, 2023	$ 280,752	$ 0	735,240	84	(454,572)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans (in shares)		622
Issuance of common stock under stock plans	2,586		2,586
Stock-based compensation expense	6,637		6,637
Unrealized gain (loss) on cash equivalents	29			29
Net loss	(25,957)				(25,957)
Balance at the end of the period (in shares) at Mar. 31, 2024		51,393
Balance at the end of the period at Mar. 31, 2024	$ 264,047	$ 0	744,463	113	(480,529)
Balance at the beginning of the period (in shares) at Dec. 31, 2023	50,771	50,771
Balance at the beginning of the period at Dec. 31, 2023	$ 280,752	$ 0	735,240	84	(454,572)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized gain (loss) on cash equivalents	(102)
Net loss	$ (72,557)
Balance at the end of the period (in shares) at Sep. 30, 2024	52,146	52,146
Balance at the end of the period at Sep. 30, 2024	$ 241,218	$ 0	768,365	(18)	(527,129)
Balance at the beginning of the period (in shares) at Mar. 31, 2024		51,393
Balance at the beginning of the period at Mar. 31, 2024	264,047	$ 0	744,463	113	(480,529)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans (in shares)		507
Issuance of common stock under stock plans	5,296		5,296
Stock-based compensation expense	8,176		8,176
Unrealized gain (loss) on cash equivalents	(114)			(114)
Net loss	(25,626)				(25,626)
Balance at the end of the period (in shares) at Jun. 30, 2024		51,900
Balance at the end of the period at Jun. 30, 2024	251,779	$ 0	757,935	(1)	(506,155)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans (in shares)		246
Issuance of common stock under stock plans	1,715		1,715
Stock-based compensation expense	8,715		8,715
Unrealized gain (loss) on cash equivalents	(17)			(17)
Net loss	$ (20,974)				(20,974)
Balance at the end of the period (in shares) at Sep. 30, 2024	52,146	52,146
Balance at the end of the period at Sep. 30, 2024	$ 241,218	$ 0	$ 768,365	$ (18)	$ (527,129)